Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis

Zsuzsanna H. McMahan, Joseph L. Sailors, Robert Toto, Nancy J. Olsen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Secondary (AA) amyloidosis is a disease that is caused by systemic deposition of amyloid fibrils. Circulating serum amyloid A protein is an acute phase reactant and levels are therefore high during inflammatory states. Chronic elevation of serum amyloid A levels Results in accumulation and deposition in various organs, leading to organ dysfunction. Unless the inciting inflammatory state can be controlled, the subsequent development of amyloidosis diminishes patient survival. We report a case of systemic amyloidosis that presented primarily as chronic diarrhea in a patient with ankylosing spondylitis. Unfortunately for the patient, the diagnosis of amyloidosis was delayed for years despite encounters with multiple physicians. Early medical intervention to control chronic inflammation is imperative and could prevent morbidity and mortality related to the development of secondary amyloidosis. Consideration of amyloidosis as a diagnosis in patients who have chronic uncontrolled inflammatory conditions is also important in preventing poor outcomes related to this disease.

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalJournal of Clinical Rheumatology
Volume16
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Ankylosing Spondylitis
Amyloidosis
Diarrhea
Serum Amyloid A Protein
Early Medical Intervention
Acute-Phase Proteins
Amyloid
Inflammation
Morbidity
Physicians
Survival
Mortality

Keywords

  • Ankylosing spondylitis
  • Chronic diarrhea
  • Secondary amyloidosis
  • Serum amyloid A
  • TNF alpha inhibitors

ASJC Scopus subject areas

  • Rheumatology

Cite this

Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis. / McMahan, Zsuzsanna H.; Sailors, Joseph L.; Toto, Robert; Olsen, Nancy J.

In: Journal of Clinical Rheumatology, Vol. 16, No. 1, 01.2010, p. 22-25.

Research output: Contribution to journalArticle

@article{8a5579a2e9a749e08824385e6cde0378,
title = "Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis",
abstract = "Secondary (AA) amyloidosis is a disease that is caused by systemic deposition of amyloid fibrils. Circulating serum amyloid A protein is an acute phase reactant and levels are therefore high during inflammatory states. Chronic elevation of serum amyloid A levels Results in accumulation and deposition in various organs, leading to organ dysfunction. Unless the inciting inflammatory state can be controlled, the subsequent development of amyloidosis diminishes patient survival. We report a case of systemic amyloidosis that presented primarily as chronic diarrhea in a patient with ankylosing spondylitis. Unfortunately for the patient, the diagnosis of amyloidosis was delayed for years despite encounters with multiple physicians. Early medical intervention to control chronic inflammation is imperative and could prevent morbidity and mortality related to the development of secondary amyloidosis. Consideration of amyloidosis as a diagnosis in patients who have chronic uncontrolled inflammatory conditions is also important in preventing poor outcomes related to this disease.",
keywords = "Ankylosing spondylitis, Chronic diarrhea, Secondary amyloidosis, Serum amyloid A, TNF alpha inhibitors",
author = "McMahan, {Zsuzsanna H.} and Sailors, {Joseph L.} and Robert Toto and Olsen, {Nancy J.}",
year = "2010",
month = "1",
doi = "10.1097/RHU.0b013e3181c78c1a",
language = "English (US)",
volume = "16",
pages = "22--25",
journal = "Journal of Clinical Rheumatology",
issn = "1076-1608",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis

AU - McMahan, Zsuzsanna H.

AU - Sailors, Joseph L.

AU - Toto, Robert

AU - Olsen, Nancy J.

PY - 2010/1

Y1 - 2010/1

N2 - Secondary (AA) amyloidosis is a disease that is caused by systemic deposition of amyloid fibrils. Circulating serum amyloid A protein is an acute phase reactant and levels are therefore high during inflammatory states. Chronic elevation of serum amyloid A levels Results in accumulation and deposition in various organs, leading to organ dysfunction. Unless the inciting inflammatory state can be controlled, the subsequent development of amyloidosis diminishes patient survival. We report a case of systemic amyloidosis that presented primarily as chronic diarrhea in a patient with ankylosing spondylitis. Unfortunately for the patient, the diagnosis of amyloidosis was delayed for years despite encounters with multiple physicians. Early medical intervention to control chronic inflammation is imperative and could prevent morbidity and mortality related to the development of secondary amyloidosis. Consideration of amyloidosis as a diagnosis in patients who have chronic uncontrolled inflammatory conditions is also important in preventing poor outcomes related to this disease.

AB - Secondary (AA) amyloidosis is a disease that is caused by systemic deposition of amyloid fibrils. Circulating serum amyloid A protein is an acute phase reactant and levels are therefore high during inflammatory states. Chronic elevation of serum amyloid A levels Results in accumulation and deposition in various organs, leading to organ dysfunction. Unless the inciting inflammatory state can be controlled, the subsequent development of amyloidosis diminishes patient survival. We report a case of systemic amyloidosis that presented primarily as chronic diarrhea in a patient with ankylosing spondylitis. Unfortunately for the patient, the diagnosis of amyloidosis was delayed for years despite encounters with multiple physicians. Early medical intervention to control chronic inflammation is imperative and could prevent morbidity and mortality related to the development of secondary amyloidosis. Consideration of amyloidosis as a diagnosis in patients who have chronic uncontrolled inflammatory conditions is also important in preventing poor outcomes related to this disease.

KW - Ankylosing spondylitis

KW - Chronic diarrhea

KW - Secondary amyloidosis

KW - Serum amyloid A

KW - TNF alpha inhibitors

UR - http://www.scopus.com/inward/record.url?scp=77950345868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950345868&partnerID=8YFLogxK

U2 - 10.1097/RHU.0b013e3181c78c1a

DO - 10.1097/RHU.0b013e3181c78c1a

M3 - Article

C2 - 20051751

AN - SCOPUS:77950345868

VL - 16

SP - 22

EP - 25

JO - Journal of Clinical Rheumatology

JF - Journal of Clinical Rheumatology

SN - 1076-1608

IS - 1

ER -